SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ·Healthcare·Biotechnology
$4.84
-0.76%
Mkt Cap $660.93M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.40 – $3.20
Implied Upside
-42.2%
Consensus $2.80 vs current $4.84
NASDAQ·Healthcare·Biotechnology
$4.84
-0.76%
Mkt Cap $660.93M
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.80
Range $2.40 – $3.20
-42.2%
Consensus $2.80 vs current $4.84